IL116615A - Transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole and of its salts - Google Patents

Transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole and of its salts

Info

Publication number
IL116615A
IL116615A IL11661595A IL11661595A IL116615A IL 116615 A IL116615 A IL 116615A IL 11661595 A IL11661595 A IL 11661595A IL 11661595 A IL11661595 A IL 11661595A IL 116615 A IL116615 A IL 116615A
Authority
IL
Israel
Prior art keywords
methyl
pyrrolidenyl
isoxazole
administration
salts
Prior art date
Application number
IL11661595A
Other languages
English (en)
Other versions
IL116615A0 (en
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL116615A0 publication Critical patent/IL116615A0/xx
Publication of IL116615A publication Critical patent/IL116615A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL11661595A 1995-01-14 1995-12-29 Transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole and of its salts IL116615A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19501022A DE19501022C1 (de) 1995-01-14 1995-01-14 Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung

Publications (2)

Publication Number Publication Date
IL116615A0 IL116615A0 (en) 1996-03-31
IL116615A true IL116615A (en) 1999-09-22

Family

ID=7751534

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11661595A IL116615A (en) 1995-01-14 1995-12-29 Transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole and of its salts

Country Status (12)

Country Link
EP (1) EP0802790B1 (xx)
JP (1) JPH10511972A (xx)
KR (1) KR19980701419A (xx)
AR (1) AR001070A1 (xx)
AT (1) ATE292458T1 (xx)
BR (1) BR9607488A (xx)
CA (1) CA2210341A1 (xx)
DE (2) DE19501022C1 (xx)
IL (1) IL116615A (xx)
NZ (1) NZ298428A (xx)
WO (1) WO1996021434A1 (xx)
ZA (1) ZA96260B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9615628D0 (en) * 1996-07-25 1996-09-04 Smithkline Beecham Plc Formulation
DE10004790B4 (de) * 2000-02-01 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung von Zaleplon, Verfahren zu seiner Herstellung und seine Verwendung
DE10019067C1 (de) * 2000-04-18 2001-10-04 Lohmann Therapie Syst Lts Transdermales Therapeutisches System zur Abgabe von Dofetilid und seine Verwendung
DE10118282A1 (de) 2001-04-12 2002-12-05 Lohmann Therapie Syst Lts Haftkleber auf Basis von Ethylen-Vinylacetat-Copolymeren und Klebharzen, für medizinische Verwendungszwecke

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2153360T3 (es) * 1991-05-29 2001-03-01 Abbott Lab Compuestos de isoxazol e de isotiazol que mejoran las funciones de razonamiento.
DE4313928C2 (de) * 1993-04-28 1996-09-19 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung
DE4336557C2 (de) * 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
US5494680A (en) * 1993-12-08 1996-02-27 Minnesota Mining And Manufacturing Company Transdermal delivery device

Also Published As

Publication number Publication date
JPH10511972A (ja) 1998-11-17
CA2210341A1 (en) 1996-07-18
DE19501022C1 (de) 1996-06-05
IL116615A0 (en) 1996-03-31
ATE292458T1 (de) 2005-04-15
EP0802790B1 (de) 2005-04-06
DE59611212D1 (de) 2005-05-12
KR19980701419A (ko) 1998-05-15
BR9607488A (pt) 1997-12-23
WO1996021434A1 (de) 1996-07-18
AR001070A1 (es) 1997-09-24
NZ298428A (en) 1999-10-28
ZA96260B (en) 1996-08-01
EP0802790A1 (de) 1997-10-29
MX9705324A (es) 1997-10-31

Similar Documents

Publication Publication Date Title
EP0739626A3 (en) Transdermal therapeutic system with controlled drug release
AU4449789A (en) Delivery system for pharmaceutical or therapeutic actives
GB2303064B (en) Medicament for nasal administration
EP0858334A4 (en) IMMEDIATE AND SLOW RELEASE ANALGESIC PHARMACEUTICAL COMPOSITION
PL330814A1 (en) Compounds for and methods of delivering pharmaceutical preparations and their application
GB9601969D0 (en) A system for the delivery of drugs and therapeutic agents
AU5397996A (en) Iontophoretic transdermal system for the administration of at least two substances
DE69326539T2 (de) Zytotoxische arzneimittel therapie
HUP0104803A3 (en) Process and system for the administration of medicine through the skin
AU2782592A (en) Thermal enhancement of transdermal drug administration
AU1429697A (en) Systems and methods for the transdermal administration of androgenic agents
ZA968905B (en) Transdermal therapeutic system (tts) for administering active substances for drug dependence or drug addiction
ZA9670B (en) Composition and methods for transdermal delivery of acid-lability drugs
HUP9801130A3 (en) Transdermal therapeutic system for administering testosterone
ZA891718B (en) Orally administered system for the controller release of active substances
GB9700737D0 (en) Administration of drugs
IL116615A (en) Transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole and of its salts
HK1015681A1 (en) Rate-controlled transdermal administration of risperidone
ZA966842B (en) Transdermal administration of vorozole.
AU4391196A (en) A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidinyl)-isoxazole or one of its pharmaceutically acceptable salts
SI0859595T1 (en) Therapeutic preparation for the transdermal administration of active substances
AU3560597A (en) Device for controlled administration of medicines
IE900913L (en) Transdermal system for controlled administration of active¹ingredients
GB9503322D0 (en) Medicament administration dummy
IL126778A0 (en) Administration of histamine for therapeutic purposes

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees